Skip to main content

European Biotech Acquisition Corp. (EBAC)

NASDAQ: EBAC · Delayed Price · USD
9.74 0.05 (0.52%)
Sep 15, 2021 4:00 PM EDT - Market closed
Market Cap159.72M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out13.21M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close9.69
Day's Range9.74 - 9.76
52-Week Range9.59 - 10.48
Price Targetn/a
Est. Earnings Daten/a

About EBAC

European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.

IndustryShell Companies
IPO DateMar 16, 2021
Stock ExchangeNASDAQ
Ticker SymbolEBAC
Full Company Profile


European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report

NEW YORK--(BUSINESS WIRE)--European Biotech Acquisition Corp. receives expected notification from Nasdaq related to delayed quarterly report.

3 months ago - Business Wire

CORRECTING and REPLACING European Biotech Acquisition Corp. Announces Pricing of Upsized $120 Million Initial Public ...

European Biotech Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 12,000,000 units at $10.00 per unit.

6 months ago - Business Wire

Eduardo Bravo returns to bring European biotech in on the SPAC splurge

The last year’s SPAC boom has been dominated so far by US-based VCs. Now a prominent European biotech executive and a couple investors are getting in on the game.

7 months ago - EndPoints News

Life sciences SPAC European Biotech Acquisition files for a $100 million IPO

European Biotech Acquisition, a blank check company formed by LSP targeting the life sciences industry in Europe, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.

7 months ago - NASDAQ

European Biotech Acquisition IPO Registration Document (S-1)

European Biotech Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC